Dr Reddy’s Laboratories
-
Bayer, Dr Reddy’s in marketing, distribution agreement for second brand of Vericiguat in India
Vericiguat is a soluble guanylate cyclase (sGC) stimulator, in India, is indicated, along with guideline-based medical therapy, in adults with…
Read More » -
Aurigene Pharmaceutical Services introduces Aurigene.AI for assisted drug discovery platform
The modular platform allows users flexibility in selecting suitable AI models from a set of generative, predictive, and computational algorithms…
Read More » -
Dr Reddy’s acquires MenoLabs
The portfolio which includes seven branded products designed to provide health support and address symptoms of perimenopause and menopause Dr…
Read More » -
Dr Reddy’s Laboratories acquires Preferred A-1 shares of Israel-based Edity Therapeutics
The funds invested by Dr Reddy’s would be utilised by Edity to further develop its technology platform Dr Reddy’s Laboratories,…
Read More » -
Coya Therapeutics, Dr Reddy’s Laboratories collaborate for investigational combination therapy to treat ALS
Coya retains the right to commercialise COYA 302 for patients with amyotrophic lateral sclerosis (ALS) in Japan, Mexico, and each…
Read More » -
Dr Reddy’s rolls out drug-free non-invasive migraine management device Nerivio in India
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migraine with or without aura for…
Read More » -
Dr Reddy’s unveils direct-to-consumer e-commerce website ‘Celevida Wellness’ for diabetes
The website will host the Celevida range of products as well as other third-party brands to offer a product portfolio…
Read More » -
Dr Reddy’s unveils dedicated division ‘RGenX’
Forays into trade generics business in India Dr Reddy’s Laboratories has announced its entry into the trade generics business in…
Read More » -
Coya Therapeutics secures global deal with Dr Reddy’s Laboratories
Coya has received an exclusive, royalty-bearing license to sell Dr Reddy’s proposed biosimilar Abatacept in several regions Coya Therapeutics has…
Read More » -
Dr Reddy’s Laboratories launches Difluprednate Ophthalmic Emulsion 0.05 per cent in US
Difluprednate Ophthalmic Emulsion 0.05 per cent is available in 5 ml bottles in case packs of 24 Dr Reddy’s Laboratories…
Read More »
